Norway· NO-ID_46D6C14D-43C6-499F-8D06-E2774862C919
Talvey
A talquetamab product containing talquetamab, registered in Norway by Janssen-Cilag International N.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Talquetamab is registered in 12 of 19 countries.
Countries holding a registration under ATC L01FX29 (talquetamab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Talquetamab · ATC L01FX29
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of talquetamab costs, country by country.
Normalised to the WHO defined daily dose (4 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Talquetamab · price per daily dose (4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$571.23
The record
At a glance
FEST (Norway)- Active substance
- Talquetamab
- Manufacturer
- Janssen-Cilag International N.V.
- Country
- Norway (NO)
- ATC code
- L01FX29
- ATC class
- Talquetamab
- Defined daily dose
- 4 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_46D6C14D-43C6-499F-8D06-E2774862C919
- no_varenummer3736251.5NOK 6385.5
- gtin7323281005780
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Talquetamab in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTalvey 2 mg/mlJanssen-Cilag International
- SwitzerlandTalvey 3 mg/1.5 ml, InjektionslösungJanssen-Cilag AG
- CzechiaTALVEYJanssen-Cilag International N.V., Beerse
- SpainTALVEY 2 MG/ML SOLUCION INYECTABLEJanssen-Cilag International N.V
- IcelandTALVEYJanssen-Cilag International NV*
- PolandTalveyJanssen-Cilag International N.V.
- SwedenTALVEY 2 mg/ml Injektionsvätska, lösningJanssen-Cilag International NV
- United StatesTALVEYJanssen Biotech, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Talvey
- Liechtenstein · Talvey
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4a8df20-7b0d-41ba-bade-6851d913d485 GET /v1/drugs/f4a8df20-7b0d-41ba-bade-6851d913d485?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Talkvetamab",
"merkevare_id": "ID_46D6C14D-43C6-499F-8D06-E2774862C919",
"name_form_strength": "Talvey inj, oppl 2 mg/ml",
"prescription_group": "C"
}See everything about talquetamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.